Quantitative analysis for Compugen Ltd. (CGEN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (62.0) (grade B). 26 signals analyzed (22 differentiated alt-data).
CGEN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $2.76 | $2.54 | $2.60 |
| 2026-05-11 | $2.98 | $2.79 | $2.87 |
| 2026-05-21 | $2.71 | $2.54 | $2.61 |
| 2026-06-03 | $2.24 | $2.12 | $2.19 |
| 2026-06-15 | $2.09 | $2.01 | $2.02 |
| 2026-06-26 | $2.10 | $2.01 | $2.09 |
| 2026-07-09 | $2.56 | $2.44 | $2.47 |
| 2026-07-21 | $2.52 | $2.34 | $2.49 |
| 2026-07-31 | $2.38 | $2.25 | $2.35 |
| 2026-08-12 | $2.50 | $2.42 | $2.50 |
| 2026-08-24 | $2.61 | $2.49 | $2.59 |
| 2026-09-03 | $2.66 | $2.54 | $2.56 |
How Compugen Ltd. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| PRLD | Prelude Therapeutics Incorporated | $251M | — |
| PRE | Prenetics Global Limited | $261M | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $264M | 65.0 |
| ZURA | Zura Bio Limited | $266M | 38.0 |
View all Health Care stocks by valuation and signals →
Compugen Ltd. (CGEN) scores Buy (62.0), with no measured dimension below 45. Its highest are analyst consensus at 79, technicals at 79, ML forecast at 68, across 4 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 79 |
| technicals | 79 |
| ML forecast | 68 |
| valuation | 45 |
StoQuant analyzes 26 signals (22 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Compugen Ltd. (CGEN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CGEN"><img src="https://stoquant.com/badge/CGEN.svg" alt="Compugen Ltd. (CGEN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.